These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30502357)

  • 1. Cannabinoid receptor type-1 partially mediates metabolic endotoxemia-induced inflammation and insulin resistance.
    Grunewald ZI; Lee S; Kirkland R; Ross M; de La Serre CB
    Physiol Behav; 2019 Feb; 199():282-291. PubMed ID: 30502357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid CB₁ receptor restrains accentuated activity of hypothalamic corticotropin-releasing factor and brainstem tyrosine hydroxylase neurons in endotoxemia-induced hypophagia in rats.
    Rorato R; Reis WL; de Carvalho Borges B; Antunes-Rodrigues J; Elias LL
    Neuropharmacology; 2012 Jul; 63(1):154-60. PubMed ID: 22138163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity.
    Mehrpouya-Bahrami P; Chitrala KN; Ganewatta MS; Tang C; Murphy EA; Enos RT; Velazquez KT; McCellan J; Nagarkatti M; Nagarkatti P
    Sci Rep; 2017 Nov; 7(1):15645. PubMed ID: 29142285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction.
    Lipina C; Vaanholt LM; Davidova A; Mitchell SE; Storey-Gordon E; Hambly C; Irving AJ; Speakman JR; Hundal HS
    Aging Cell; 2016 Apr; 15(2):325-35. PubMed ID: 26757949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPS-Induced Low-Grade Inflammation Increases Hypothalamic JNK Expression and Causes Central Insulin Resistance Irrespective of Body Weight Changes.
    Rorato R; Borges BC; Uchoa ET; Antunes-Rodrigues J; Elias CF; Elias LLK
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28677618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
    Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food intake-independent effects of CB1 antagonism on glucose and lipid metabolism.
    Cota D; Sandoval DA; Olivieri M; Prodi E; D'Alessio DA; Woods SC; Seeley RJ; Obici S
    Obesity (Silver Spring); 2009 Aug; 17(8):1641-5. PubMed ID: 19325539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes.
    Lu D; Dopart R; Kendall DA
    Cell Stress Chaperones; 2016 Jan; 21(1):1-7. PubMed ID: 26498013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia.
    Caraceni P; Pertosa AM; Giannone F; Domenicali M; Grattagliano I; Principe A; Mastroleo C; Perrelli MG; Cutrin J; Trevisani F; Croci T; Bernardi M
    Gut; 2009 Aug; 58(8):1135-43. PubMed ID: 19282305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of inflammation-induced impairment of glucose uptake in adipocytes by direct effect of CB1 antagonism on adipose tissue macrophages.
    Miranville A; Herling AW; Biemer-Daub G; Voss MD
    Obesity (Silver Spring); 2010 Dec; 18(12):2247-54. PubMed ID: 20379144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Cannabinoid Receptor 1 Can Influence the Lipid Metabolism in Mice with Diet-Induced Obesity.
    Wei LW; Yuan ZQ; Zhao MD; Gu CW; Han JH; Fu L
    Biochemistry (Mosc); 2018 Oct; 83(10):1279-1287. PubMed ID: 30472964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in hypothalamic AMPK phosphorylation induced by prolonged exposure to LPS involves ghrelin and CB1R signaling.
    Rivas PMS; Vechiato FMV; Borges BC; Rorato R; Antunes-Rodrigues J; Elias LLK
    Horm Behav; 2017 Jul; 93():166-174. PubMed ID: 28576646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic endotoxemia initiates obesity and insulin resistance.
    Cani PD; Amar J; Iglesias MA; Poggi M; Knauf C; Bastelica D; Neyrinck AM; Fava F; Tuohy KM; Chabo C; Waget A; Delmée E; Cousin B; Sulpice T; Chamontin B; Ferrières J; Tanti JF; Gibson GR; Casteilla L; Delzenne NM; Alessi MC; Burcelin R
    Diabetes; 2007 Jul; 56(7):1761-72. PubMed ID: 17456850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia.
    Santos-Molina L; Herrerias A; Zawatsky CN; Gunduz-Cinar O; Cinar R; Iyer MR; Wood CM; Lin Y; Gao B; Kunos G; Godlewski G
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus.
    Rorato R; Miyahara C; Antunes-Rodrigues J; Elias LL
    Regul Pept; 2013 Mar; 182():12-8. PubMed ID: 23327999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.
    Thornton-Jones ZD; Kennett GA; Benwell KR; Revell DF; Misra A; Sellwood DM; Vickers SP; Clifton PG
    Pharmacol Biochem Behav; 2006 Jun; 84(2):353-9. PubMed ID: 16814374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
    Ravinet Trillou C; Delgorge C; Menet C; Arnone M; Soubrié P
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.
    Chang E; Kim DH; Yang H; Lee DH; Bae SH; Park CY
    PLoS One; 2018; 13(10):e0206152. PubMed ID: 30365523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Weight Gain and Insulin Resistance in HF-Fed PLTP Deficient Mice Is Related to Altered Inflammatory Response and Plasma Transport of Gut-Derived LPS.
    Lebrun LJ; Pallot G; Nguyen M; Tavernier A; Dusuel A; Pilot T; Deckert V; Dugail I; Le Guern N; Pais De Barros JP; Benkhaled A; Choubley H; Lagrost L; Masson D; Gautier T; Grober J
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase.
    McGown CC; Brown NJ; Hellewell PG; Brookes ZL
    Microvasc Res; 2011 May; 81(3):281-8. PubMed ID: 21354186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.